The Acute STroke Registry and Analysis of Lausanne (ASTRAL): Design and Baseline Analysis of an Ischemic Stroke Registry Including Acute Multimodal Imaging
暂无分享,去创建一个
R. Meuli | M. Wintermark | M. Reichhart | P. Maeder | M. Faouzi | P. Michel | A. Croquelois | G. Ntaios | M. Rutgers | C. Odier | A. Maghraoui
[1] D. Miglioretti,et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. , 2009, Archives of internal medicine.
[2] M. Hennerici. Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study , 2009, Cerebrovascular Diseases.
[3] H. Mattle,et al. Stroke events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. , 2009, Swiss medical weekly.
[4] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[5] A. Arboix,et al. Trends in Risk Factors, Stroke Subtypes and Outcome , 2008, Cerebrovascular Diseases.
[6] K. Laederach-Hofmann,et al. Heart failure events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. , 2008, Swiss medical weekly.
[7] Gary A. Ford,et al. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. , 2008, Cerebrovascular diseases.
[8] E. Ringelstein,et al. Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients , 2007, Journal of Neurology.
[9] H. Thomsen. ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis , 2007, European Radiology.
[10] A. Demchuk,et al. Incidence of Radiocontrast Nephropathy in Patients Undergoing Acute Stroke Computed Tomography Angiography , 2007, Stroke.
[11] K. Ghandehari,et al. Khorasan stroke registry: analysis of 1392 stroke patients. , 2007, Archives of Iranian medicine.
[12] M. Maeder-Ingvar,et al. Trends in Risk Factors, Patterns and Causes in Hospitalized Strokes over 25 Years: The Lausanne Stroke Registry , 2007, Cerebrovascular Diseases.
[13] Deepak L. Bhatt,et al. One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.
[14] Gelin Xu,et al. Subtypes and One-Year Survival of First-Ever Stroke in Chinese Patients: The Nanjing Stroke Registry , 2006, Cerebrovascular Diseases.
[15] Reto Meuli,et al. Perfusion-CT Assessment of Infarct Core and Penumbra: Receiver Operating Characteristic Curve Analysis in 130 Patients Suspected of Acute Hemispheric Stroke , 2006, Stroke.
[16] J. Bogousslavsky,et al. Thrombolyse de lattaque cérébrale ischémique: recommandations actualisées , 2006 .
[17] J. Bogousslavsky,et al. Penumbra is brain: No excuse not to perfuse , 2005, Annals of neurology.
[18] K. Furie,et al. An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.
[19] S. Gutnikov,et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) , 2004, The Lancet.
[20] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[21] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[22] Jean-Philippe Thiran,et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.
[23] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[24] H. Diener,et al. Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank , 2001, Stroke.
[25] Hyo Suk Nam,et al. Yonsei Stroke Registry , 2001, Cerebrovascular Diseases.
[26] Byung Ik. Analysis of 1,000 Patients with Acute Cerebral Infarctions , 2001 .
[27] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[28] P. Akins,et al. Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.
[29] J. Lekakis,et al. The Athens Stroke Registry: Results of a Five-Year Hospital-Based Study , 2000, Cerebrovascular Diseases.
[30] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[31] E. Kumral,et al. The Ege Stroke Registry: A Hospital-Based Study in the Aegean Region, Izmir, Turkey , 1998, Cerebrovascular Diseases.
[32] N. Bornstein,et al. The Tel Aviv Stroke Registry. 3600 consecutive patients. , 1996, Stroke.
[33] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[34] K. Blennow,et al. White‐matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors , 1991, Acta neurologica Scandinavica.
[35] J. Bogousslavsky,et al. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. , 1988, Stroke.
[36] J. Mohr,et al. Stroke data banks. , 1986, Stroke.
[37] S. Hatano,et al. Experience from a multicentre stroke register: a preliminary report. , 1976, Bulletin of the World Health Organization.
[38] L. Wilkins. A Classification and Outline of Cerebrovascular Diseases II , 1975, Stroke.
[39] A Classification and Outline of the Cerebrovascular Diseases , 1958, Neurology.